Equities

Owens & Minor Inc

Owens & Minor Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)12.90
  • Today's Change0.14 / 1.10%
  • Shares traded916.77k
  • 1 Year change-30.19%
  • Beta0.4090
Data delayed at least 15 minutes, as of Nov 08 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Owens & Minor, Inc. is a global healthcare solutions company providing essential products and services that support care from the hospital to the home. The Company operates through two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a comprehensive portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products purchased from manufacturers and its own proprietary products. Its service offerings to healthcare providers include supplier management, analytics, inventory management, and clinical supply management. It also offers a variety of programs providing outsourced logistics and marketing solutions to its suppliers as well. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and a provider of integrated home healthcare equipment and related services.

  • Revenue in USD (TTM)10.66bn
  • Net income in USD-48.79m
  • Incorporated1993
  • Employees13.70k
  • Location
    Owens & Minor Inc9120 LOCKWOOD BLVDMECHANICSVILLE 23116United StatesUSA
  • Phone+1 (804) 723-7000
  • Fax+1 (804) 723-7100
  • Websitehttps://www.owens-minor.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Iradimed Corp71.31m18.63m715.67m148.0038.678.5836.7910.041.461.465.596.590.78511.426.16481,791.5020.5113.1622.4814.5877.1476.5526.1221.467.82143.270.0068.1323.0016.5934.0222.2297.77--
Orthofix Medical Inc771.65m-120.49m741.74m1.63k--1.41--0.9458-3.21-3.2120.5514.350.86541.176.49479,956.60-13.51-8.88-16.22-10.9667.1872.37-15.62-9.281.13-4.940.2005--62.0610.51-666.60--30.01--
Standard Biotools Inc155.90m-170.60m800.36m534.00--1.64--5.13-0.7091-0.70910.55791.310.30542.486.01291,951.30-24.41-28.17-29.37-33.6048.5751.58-79.91-74.853.41--0.1014--8.57-1.2060.73--50.06--
Figs Inc548.65m10.84m816.71m354.0081.002.0149.311.490.0590.0593.082.381.111.3365.261,549,845.002.20--2.64--67.67--1.97--3.28--0.00--7.87--6.85------
Embecta Corp1.12bn69.70m896.69m2.20k12.88--8.280.80141.211.2119.36-13.240.88822.1111.60508,590.905.53--7.91--66.42--6.23--1.612.061.88---0.7703---68.52------
Cytek Biosciences Inc201.21m-10.16m927.11m645.00--2.37--4.61-0.0782-0.07821.522.970.39821.603.72297,647.90-2.01---2.29--54.92---5.05--5.47--0.0032--17.67---571.58------
Castle Biosciences Inc311.88m6.08m932.36m610.00166.522.1147.742.990.19990.199911.0715.770.65629.157.15511,275.401.28-9.431.40-10.1781.9080.581.95-28.467.64--0.0228--60.3857.3514.41--117.94--
Avanos Medical Inc681.50m21.70m937.98m3.77k43.620.762713.881.380.46790.338514.7026.760.40311.905.16180,721.301.28-0.65271.45-0.733855.5154.453.18-1.601.469.840.1164---1.580.6357-146.05---18.37--
Bioventus Inc536.89m-41.96m959.25m1.03k--6.34--1.79-0.6595-0.65958.481.860.65911.954.18553,495.90-6.70-5.52-9.65-7.2766.5368.25-10.16-10.940.9561.080.6697--0.04459.936.91--23.51--
Owens & Minor, Inc.10.66bn-48.79m994.71m13.70k--1.144.490.0933-0.6346-0.6346139.2711.352.097.2615.86778,172.30-0.95611.32-1.492.0720.7216.48-0.45760.56140.45192.030.68310.7983.801.87-284.47--25.91--
CeriBell Inc-100.00bn-100.00bn1.01bn----------------0.5919------------------------3.53--0.4912--74.47--20.72------
Artivion Inc376.97m-8.32m1.20bn1.50k--4.0780.133.19-0.2076-0.20769.117.060.4811.675.44251,316.00-1.07-2.20-1.15-2.3664.6365.51-2.22-5.344.041.070.5177--12.826.14-60.09--5.13--
BioLife Solutions Inc121.17m-53.87m1.21bn409.00--3.75--9.95-1.21-1.642.696.970.29991.995.39296,254.30-13.33-13.76-14.60-15.0441.2736.76-44.46-42.991.81-5.980.0651---11.4348.6552.49--86.35--
Pulse Biosciences Inc0.00-46.13m1.22bn56.00--15.45-----0.8069-0.80690.001.290.00----0.00-58.03-93.21-62.84-104.99-------12,332.25----0.00---100.00--27.85---15.20--
Establishment Labs Holdings Inc151.35m-83.20m1.29bn857.00--28.71--8.54-3.11-3.115.621.610.53070.85252.72166,685.00-29.17-33.22-34.29-41.1266.0464.73-54.97-43.192.91-20.680.8114--2.1321.96-4.38--69.16--
Data as of Nov 08 2024. Currency figures normalised to Owens & Minor Inc's reporting currency: US Dollar USD

Institutional shareholders

65.35%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 202410.71m13.89%
Fidelity Management & Research Co. LLCas of 30 Jun 20249.16m11.88%
The Vanguard Group, Inc.as of 30 Jun 20248.43m10.94%
Pacer Advisors, Inc.as of 30 Jun 20246.79m8.80%
Dimensional Fund Advisors LPas of 30 Sep 20244.60m5.97%
SSgA Funds Management, Inc.as of 30 Jun 20242.99m3.87%
FIAM LLCas of 30 Jun 20242.32m3.01%
Janus Henderson Investors US LLCas of 30 Jun 20241.86m2.42%
Charles Schwab Investment Management, Inc.as of 30 Jun 20241.84m2.39%
Geode Capital Management LLCas of 30 Jun 20241.70m2.20%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.